United Therapeutics (UTHR) Misses Q3 EPS by 16c
Tweet
Share
E-mail
Get Alerts UTHR Hot Sheet
Price: $497.11 -1.34%
Revenue Growth %: -1.2%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
ANAB, ANIX, MNY, More
Revenue Growth %: -1.2%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $7.16, $0.16 worse than the analyst estimate of $7.32. Revenue for the quarter came in at $799.5 million versus the consensus estimate of $812.87 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- Zenas BioPharma (ZBIO) files for up to 7M share offering by selling stockholders
- Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
